ANGPTL3 and Nephropathy: The present results suggested that antagonists or inhibitors such as small molecule drugs or antibodies targeting Angptl3 might be specific and effective candidate therapeutic approaches for podocyte injury and proteinuria in nephropathy, and if those therapeutic approaches were used in treatments, continuously maintaining a low level of Angptl3 (long-term medication) would have better effectiveness.